Drugs / Selenium methionine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04683575 | May 2022 → Dec 2025 | metastatic neoplasm, thyroid cancer | Qianfoshan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Selenium methionine | “The active agent in selenium yeast supplements is known as selenium methionine (SEMET).” NCT04683575 ↗ |
| Known as | SEMET | “The active agent in selenium yeast supplements is known as selenium methionine (SEMET).” NCT04683575 ↗ |